Anand Mahadevan
Overview
Explore the profile of Anand Mahadevan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
96
Citations
1919
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Udovicich C, Koo K, Bryant J, Bugarini A, Huo M, Kim K, et al.
Radiother Oncol
. 2024 Nov;
202:110641.
PMID: 39579871
Background And Purpose: Neoadjuvant stereotactic radiosurgery (NaSRS) is an emerging treatment option for brain metastases (BrM) planned for resection. The aim of this study was to report on the efficacy...
2.
Snider J, Snider J, Mayr N, Molitoris J, Chhabra A, Mossahebi S, et al.
Pract Radiat Oncol
. 2024 Oct;
PMID: 39447865
Purpose: Since the inaugural workshop "Understanding High-Dose, Ultra-High Dose Rate and Spatially Fractionated Radiotherapy." hosted by the National Cancer Institute and sponsored by the Radiosurgery Society (RSS), growing collaborations and...
3.
Tan V, Correa R, Warner A, Ali M, Muacevic A, Ponsky L, et al.
Eur Urol Oncol
. 2024 Jul;
7(6):1527-1534.
PMID: 38987159
Background And Objective: Renal function preservation is particularly important following nonoperative treatment of localized renal cell carcinoma (RCC) since patients are often older with medical comorbidities. Our objective was to...
4.
Liu J, Sidiqi B, McComas K, Gogineni E, Andraos T, Crane C, et al.
Pract Radiat Oncol
. 2024 Jul;
14(6):555-573.
PMID: 38986901
The use of radiation therapy (RT) for pancreatic cancer continues to be controversial, despite recent technical advances. Improvements in systemic control have created an evolving role for RT and the...
5.
Lischalk J, Sanchez A, Santos V, Mendez C, Akerman M, Carpenter T, et al.
Radiat Oncol
. 2024 Mar;
19(1):29.
PMID: 38439040
Purpose: Percentage of positive cores involved on a systemic prostate biopsy has been established as a risk factor for adverse oncologic outcomes and is a National Comprehensive Cancer Network (NCCN)...
6.
Gurewitz J, Mahadevan A, Cooper B
Pract Radiat Oncol
. 2024 Jan;
14(3):189-195.
PMID: 38163632
No abstract available.
7.
Hurwitz J, Haas J, Mendez C, Sanchez A, Santos V, Akerman M, et al.
Pract Radiat Oncol
. 2023 Nov;
14(3):241-251.
PMID: 37984713
Purpose: Historically, toxicity concerns have existed in patients with large prostate glands treated with radiation therapy, particularly brachytherapy. There are questions whether this risk extends to stereotactic body radiation therapy...
8.
Milano M, Mavroidis P, Ryckman J, Yorke E, Doucette C, Mahadevan A, et al.
Radiother Oncol
. 2023 Feb;
182:109583.
PMID: 36842665
Introduction: Radiation-induced brachial plexopathy (RIBP), resulting in symptomatic motor or sensory deficits of the upper extremity, is a risk after exposure of the brachial plexus to therapeutic doses of radiation....
9.
Milano M, Doucette C, Mavroidis P, Yorke E, Ryckman J, Mahadevan A, et al.
Int J Radiat Oncol Biol Phys
. 2023 Jan;
118(4):931-943.
PMID: 36682981
We sought to systematically review and summarize dosimetric factors associated with radiation-induced brachial plexopathy (RIBP) after stereotactic body radiation therapy (SBRT) or hypofractionated image guided radiation therapy (HIGRT). From published...
10.
Grimm J, Naidoo S, Yossef K, Shukla G, Scofield C, Searfoss A, et al.
Cureus
. 2022 Nov;
14(10):e30676.
PMID: 36439614
Purpose: Utilization of breathhold scans with live tracking has a long track record of good published outcomes for stereotactic body radiation therapy (SBRT) and is recommended by the manufacturer of...